Ignite Creation Date:
2024-07-17 @ 11:39 AM
Last Modification Date:
2024-10-26 @ 3:33 PM
Study NCT ID:
NCT06475820
Status:
ACTIVE_NOT_RECRUITING
Last Update Posted:
2024-06-26
First Post:
2024-05-17
Brief Title:
Preventing of GVHD With Post-transplantation Cyclophosphamide Abatacept Vedolizumab and Baricitinib at Children and Young Adults With Hemoblastosis
Sponsor:
Federal Research Institute of Pediatric Hematology Oncology and Immunology
Organization:
Federal Research Institute of Pediatric Hematology Oncology and Immunology
Organization Data
Organization:
Federal Research Institute of Pediatric Hematology Oncology and Immunology
Class:
OTHER
Study ID:
NCHPOI-2023-07
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Federal Research Institute of Pediatric Hematology Oncology and Immunology
Lead Sponsor Class:
OTHER
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None